The treatment of Kallikrein on Peripheral Arterial Diseases in Type 2 Diabetes Mellitus: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003175

Enrollment

Unknown

Registered

2013-04-19

Start date

2013-05-31

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes and peripheral arterial disease

Interventions

1:TK

2:Control

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clear consciousness, have a history of diabetes, in line with the especially Guidelines for the diagnosis of PAD patients with diabetes mellitus with the International Working Group on the diabetic foot and peripheral artery disease in 2011; 2. stable vital signs; 3. All patients provided fully informed consent.

Exclusion criteria

Exclusion criteria: 1. PAD is not the result of diabetes disease; 2. pregnancy or lactation period; 3. patients with unstable vital signs, etc.; 4. Not expected to complete follow-up; 5. the presence of TK use contraindication.

Design outcomes

Primary

Measure	Time frame
FMD;IMT;TWD;the area of the plaque;	—

Countries

China

Contacts

Public ContactLiu Ling

liuling8210@126.com+86 15195886395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026